Source:http://linkedlifedata.com/resource/pubmed/id/17409234
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
14
|
pubmed:dateCreated |
2007-4-5
|
pubmed:abstractText |
Despite the introduction of highly active antiretroviral therapy, dementia caused by human immunodeficiency virus-1 (HIV-1) infection remains a devastating and common neurological disorder. Although the mechanisms governing neurodegeneration during HIV-1 infection remain uncertain, the HIV-1 accessory protein, viral protein R (Vpr), has been proposed as a neurotoxic protein. Herein, we report that Vpr protein and transcript were present in the brains of HIV-infected persons. Moreover, soluble Vpr caused neuronal apoptosis, involving cytochrome c extravasation, p53 induction, and activation of caspase-9 while exerting a depressive effect on whole-cell currents in neurons (p < 0.05), which was inhibited by iberiotoxin. Vpr-activated glial cells secreted neurotoxins in a concentration-dependent manner (p < 0.001). Transgenic (Tg) mice expressing Vpr in brain monocytoid cells displayed the transgene principally in the basal ganglia (p < 0.05) and cerebral cortex (p < 0.01) compared with hindbrain expression. Vpr was released from cultured transgenic macrophages, which was cytotoxic to neurons and was blocked by anti-Vpr antibody (p < 0.05). Neuronal injury was observed in Tg animals compared with wild-type littermates, chiefly affecting GAD65 (p < 0.01) and vesicular acetylcholine transferase (p < 0.001) immunopositive neuronal populations in the basal ganglia. There was also a loss of subcortical synaptophysin (p < 0.001) immunoreactivity as well as an increase in activated caspase-3, which was accompanied by a hyperexcitable neurobehavioral phenotype (p < 0.05). Thus, HIV-1 Vpr caused neuronal death through convergent pathogenic mechanisms with ensuing in vivo neurodegeneration, yielding new insights into the mechanisms by which HIV-1 injures the nervous system.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1529-2401
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
4
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3703-11
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17409234-Animals,
pubmed-meshheading:17409234-Apoptosis,
pubmed-meshheading:17409234-Cell Line, Tumor,
pubmed-meshheading:17409234-Gene Products, vpr,
pubmed-meshheading:17409234-HIV-1,
pubmed-meshheading:17409234-Humans,
pubmed-meshheading:17409234-Mice,
pubmed-meshheading:17409234-Mice, Transgenic,
pubmed-meshheading:17409234-Nerve Degeneration,
pubmed-meshheading:17409234-Neurons,
pubmed-meshheading:17409234-Rats,
pubmed-meshheading:17409234-Rats, Sprague-Dawley,
pubmed-meshheading:17409234-vpr Gene Products, Human Immunodeficiency Virus
|
pubmed:year |
2007
|
pubmed:articleTitle |
HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration.
|
pubmed:affiliation |
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada T2N 4N1.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|